Cargando…
Phytochemicals and PI3K Inhibitors in Cancer—An Insight
In today's world of modern medicine and novel therapies, cancer still remains to be one of the prime contributor to the death of people worldwide. The modern therapies improve condition of cancer patients and are effective in early stages of cancer but the advanced metastasized stage of cancer...
Autores principales: | Suvarna, Vasanti, Murahari, Manikanta, Khan, Tabassum, Chaubey, Pramila, Sangave, Preeti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736021/ https://www.ncbi.nlm.nih.gov/pubmed/29311925 http://dx.doi.org/10.3389/fphar.2017.00916 |
Ejemplares similares
-
miRNA and antisense oligonucleotide-based α-synuclein targeting as disease-modifying therapeutics in Parkinson’s disease
por: Suvarna, Vasanti, et al.
Publicado: (2022) -
Bone Health and Natural Products- An Insight
por: Suvarna, Vasanti, et al.
Publicado: (2018) -
Comparing PI3K/Akt Inhibitors Used in Ovarian Cancer Treatment
por: Wu, Yi-Hui, et al.
Publicado: (2020) -
Significance of Ligand-Anchored Polymers for Drug Targeting in the Treatment of Colonic Disorders
por: Chaubey, Pramila, et al.
Publicado: (2020) -
Investigation into the Role of PI3K and JAK3 Kinase Inhibitors in Murine Models of Asthma
por: Wagh, Akshaya D., et al.
Publicado: (2017)